Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90

Author：                      

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.27, Iss.3, 2011-01, pp. : 441-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiosensitization of human lung cancer cells by the novel purine-scaffold Hsp90 inhibitor, PU-H71

By              

International Journal of Molecular Medicine, Vol. 33, Iss. 3, 2014-01 ,pp. : 559-564

Spandidos Publications

Access to resources Recommend Favorite

AIDing cancer treatment: Reducing AID activity via HSP90 inhibition

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 8, 2015-08 ,pp. : 2208-2211

John Wiley & Sons Inc

Access to resources Recommend Favorite

ATF2 contributes to cisplatin resistance in non‐small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 11, 2015-06 ,pp. : 2598-2609

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐level expression of Hsp90β is associated with poor survival in resectable non‐small‐cell lung cancer patients

By  

HISTOPATHOLOGY, Vol. 309-0167, Iss. 4, 2015-10 ,pp. : 509-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐level expression of Hsp90β is associated with poor survival in resectable non‐small‐cell lung cancer patients

By  

HISTOPATHOLOGY, Vol. 67, Iss. 4, 2015-10 ,pp. : 509-519

John Wiley & Sons Inc

Access to resources Recommend Favorite